Загрузка...
Efficacy and Safety of Rituximab in Chinese Children With Refractory Anti-NMDAR Encephalitis
Purpose: To assess the efficacy and safety of rituximab treatment as second-line immunotherapy in pediatric cases of anti-NMDA receptor (NMDAR) encephalitis. Methods: We retrospectively recruited 8 patients with anti-NMDAR encephalitis who were treated with rituximab as second-line immunotherapy. We...
Сохранить в:
| Опубликовано в: : | Front Neurol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7767921/ https://ncbi.nlm.nih.gov/pubmed/33381080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.606923 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|